PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 15 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A herbal pair of Salvia miltiorrhiza Bunge and Pueraria montana var. lobata reduced fasting blood glucose and adjusted related biochemical indexes [PMID:36796216]
A mixture of P. montana and red ginseng extracts reversed learning and memory impairments and inhibited acetylcholinesterase (AChE) activity in a mouse model [PMID:30263850]
Puerariae Radix and Puerariae Flos are noted for potential in ameliorating inflammation and liver injury [PMID:24716123]; Ge-Zhi-Jie-Jiu decoction (containing Ge Hua and Ge Gen) alleviated acute alcoholic liver injury in mice [PMID:39313140]
Pueraria montana var. lobata is identified as a natural product with potential for the treatment of drug addiction [PMID:36285806]
Evidence summary
PubMed sources
- 1.PMID: 40218975 (2025) — Dual Action of Pueraria montana var. lobata Extract on Myogenesis and Muscle Atrophy. · Nutrients
- 2.PMID: 36285806 (2022) — Natural Products for the Treatment of Drug Addiction: Narrative Review. · Chemistry & biodiversity
- 3.PMID: 36557824 (2022) — An Analysis of the Plant- and Animal-Based Hydrocolloids as Byproducts of the Food Industry. · Molecules (Basel, Switzerland)
- 4.PMID: 30954034 (2019) — Pueraria montana var. lobata root extract inhibits photoaging on skin through Nrf2 pathway. · Journal of microbiology and biotechnology
- 5.PMID: 26229064 (2015) — Heterogeneity of clonal patterns among patches of kudzu, Pueraria montana var. lobata, an invasive plant.